Zydus Gives Up Attempt To Market Generic Astelin
Zydus Pharmaceuticals USA Inc. has admitted to infringing Meda Pharmaceuticals Inc.'s patent for azelastine hydrochloride nasal spray and consented not to attempt to market a generic version without Meda's consent....To view the full article, register now.
Already a subscriber? Click here to view full article